Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
32.57
-0.76 (-2.28%)
Apr 29, 2026, 2:16 PM EDT - Market open
Stoke Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 84.22 | 127.98 | 191.44 | 113.56 | 144.9 | Upgrade
|
| Short-Term Investments | 200.45 | 88.92 | 9.95 | 116.04 | 74.92 | Upgrade
|
| Cash & Short-Term Investments | 284.67 | 216.9 | 201.39 | 229.6 | 219.81 | Upgrade
|
| Cash Growth | 31.25% | 7.70% | -12.28% | 4.45% | -23.49% | Upgrade
|
| Accounts Receivable | 5.94 | 1.67 | - | - | - | Upgrade
|
| Other Receivables | 1.97 | 0.7 | 0.06 | 0.59 | 0.13 | Upgrade
|
| Receivables | 7.91 | 2.37 | 0.06 | 0.59 | 0.13 | Upgrade
|
| Prepaid Expenses | 8.74 | 11.12 | 11.32 | 10.93 | 6.94 | Upgrade
|
| Restricted Cash | 0.49 | 0.08 | - | - | - | Upgrade
|
| Other Current Assets | 3.9 | 2.3 | 2.56 | 2.96 | 2.33 | Upgrade
|
| Total Current Assets | 305.7 | 232.76 | 215.34 | 244.07 | 229.22 | Upgrade
|
| Property, Plant & Equipment | 6.25 | 8.25 | 12.43 | 11.43 | 9.08 | Upgrade
|
| Long-Term Investments | 106.26 | 29.82 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.23 | 0.72 | 0.57 | 0.57 | 0.57 | Upgrade
|
| Total Assets | 418.43 | 271.56 | 228.34 | 256.07 | 238.87 | Upgrade
|
| Accounts Payable | 4.94 | 2.5 | 1.7 | 0.77 | 2.39 | Upgrade
|
| Accrued Expenses | 36.97 | 15.49 | 10.9 | 12.88 | 12.71 | Upgrade
|
| Current Portion of Leases | 3.01 | 2.32 | 2.06 | 2.36 | 1.51 | Upgrade
|
| Current Unearned Revenue | 11.9 | 18.99 | 15.31 | 14.88 | - | Upgrade
|
| Other Current Liabilities | 1.06 | 0.75 | 0.86 | 0.51 | 0.54 | Upgrade
|
| Total Current Liabilities | 57.88 | 40.06 | 30.82 | 31.39 | 17.14 | Upgrade
|
| Long-Term Leases | 1.14 | 2.45 | 4.77 | 2.72 | 3.53 | Upgrade
|
| Long-Term Unearned Revenue | 6.96 | - | 33.07 | 36.86 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.03 | 0.11 | 0.25 | 0.42 | Upgrade
|
| Total Liabilities | 65.98 | 42.53 | 68.78 | 71.22 | 21.09 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 849.62 | 720 | 561.43 | 483.17 | 414.02 | Upgrade
|
| Retained Earnings | -497.72 | -490.83 | -401.85 | -297.15 | -196.08 | Upgrade
|
| Comprehensive Income & Other | 0.54 | -0.15 | -0.02 | -1.18 | -0.17 | Upgrade
|
| Total Common Equity | 352.46 | 229.02 | 159.57 | 184.85 | 217.78 | Upgrade
|
| Shareholders' Equity | 352.46 | 229.02 | 159.57 | 184.85 | 217.78 | Upgrade
|
| Total Liabilities & Equity | 418.43 | 271.56 | 228.34 | 256.07 | 238.87 | Upgrade
|
| Total Debt | 4.15 | 4.77 | 6.84 | 5.08 | 5.04 | Upgrade
|
| Net Cash (Debt) | 386.78 | 241.95 | 194.56 | 224.52 | 214.77 | Upgrade
|
| Net Cash Growth | 59.86% | 24.36% | -13.34% | 4.54% | -24.95% | Upgrade
|
| Net Cash Per Share | 6.53 | 4.48 | 4.42 | 5.77 | 5.85 | Upgrade
|
| Filing Date Shares Outstanding | 59.15 | 54.08 | 46.3 | 44.15 | 37.36 | Upgrade
|
| Total Common Shares Outstanding | 58.92 | 54.03 | 45.92 | 39.44 | 36.9 | Upgrade
|
| Working Capital | 247.83 | 192.7 | 184.52 | 212.68 | 212.08 | Upgrade
|
| Book Value Per Share | 5.98 | 4.24 | 3.47 | 4.69 | 5.90 | Upgrade
|
| Tangible Book Value | 352.46 | 229.02 | 159.57 | 184.85 | 217.78 | Upgrade
|
| Tangible Book Value Per Share | 5.98 | 4.24 | 3.47 | 4.69 | 5.90 | Upgrade
|
| Machinery | 10.46 | 10.31 | 10.14 | 8.57 | 4.93 | Upgrade
|
| Construction In Progress | 0.62 | 0.12 | 0.07 | 0.45 | 1.61 | Upgrade
|
| Leasehold Improvements | 2.21 | 2.33 | 2.29 | 1.87 | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.